Lorusso,
Adjei,
Varterasian,
Gadgeel,
Reid,
Mitchell,
Hanson,
DeLuca,
Bruzek,
Piens,
Asbury,
Van Becelaere,
Herrera,
Sebolt-Leopold,
Meyer,
- Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies. Lorusso, P.M., Adjei, A.A., Varterasian, M., Gadgeel, S., Reid, J., Mitchell, D.Y., Hanson, L., DeLuca, P., Bruzek, L., Piens, J., Asbury, P., Van Becelaere, K., Herrera, R., Sebolt-Leopold, J., Meyer, M.B. J. Clin. Oncol. (2005)